Literature DB >> 27891010

Chronic obstructive pulmonary disease and cardiac comorbidities: A cross-sectional study.

Varuna Jethani1, Girish Sindhwani1.   

Abstract

Entities:  

Year:  2016        PMID: 27891010      PMCID: PMC5112838          DOI: 10.4103/0970-2113.192866

Source DB:  PubMed          Journal:  Lung India        ISSN: 0970-2113


× No keyword cloud information.
Sir, We read the article, “Chronic obstructive pulmonary disease and cardiac comorbidities: A cross-sectional study” by Kaushal et al.[1] with great interest. The study is useful as we come across these conditions in day-to-day practice. During reading of the article, we came across some points which we felt worth discussing. First, the authors have stated the definition of pulmonary hypertension (PH) as systolic pulmonary arterial pressure (sPAP) >30 mmHg. As per the recommendations of the European Respiratory Society guidelines, the definition of PH >30 mmHg is calculated by the right heart catheterization and not by echocardiography. However, in the present study, the sPAP is measured by echocardiography. Hence, using this value for defining PH is questionable, keeping in mind that PH measured by echocardiography is not fully reliable, especially if lung hyperinflation increases.[2345] Moreover, echocardiography being an operator-dependent procedure between operator variability may be large and will give false high values of pulmonary arterial pressure (PAP). Second, the authors have not mentioned whether patients with exacerbation of chronic obstructive pulmonary disease or patients recovering from exacerbation were included or not. As it has been reported[67] that during COPD exacerbation the pulmonary arterial pressure rise by 20 mmHg thus if 2 D echo or Rt heart catherization done during COPD exacerbation it can give false high value of PAP. Thus test should be done after stabilization of patient Last but not the least, authors have calculated the mean duration of smoking in their subjects but have not calculated the association between smoking index and prevalence of cardiac comorbidities. The studies have shown the association of smoking with many cardiac comorbidities, especially PH with a linear correlation.[8]

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  8 in total

1.  Tobacco smoke: a risk factor for pulmonary arterial hypertension? A case-control study.

Authors:  Regula Schiess; Oliver Senn; Manuel Fischler; Lars C Huber; Serap Vatandaslar; Rudolf Speich; Silvia Ulrich
Journal:  Chest       Date:  2010-05-14       Impact factor: 9.410

Review 2.  Pulmonary hypertension associated with chronic obstructive pulmonary disease.

Authors:  Sunil K Chhabra
Journal:  Indian J Chest Dis Allied Sci       Date:  2010 Jan-Mar

Review 3.  Definitions and diagnosis of pulmonary hypertension.

Authors:  Marius M Hoeper; Harm Jan Bogaard; Robin Condliffe; Robert Frantz; Dinesh Khanna; Marcin Kurzyna; David Langleben; Alessandra Manes; Toru Satoh; Fernando Torres; Martin R Wilkins; David B Badesch
Journal:  J Am Coll Cardiol       Date:  2013-12-24       Impact factor: 24.094

4.  Factors contributing to the reversible pulmonary hypertension of patients with acute respiratory failure studies by serial observations during recovery.

Authors:  A S Abraham; R B Cole; I D Green; R B Hedworth-Whitty; S W Clarke; J M Bishop
Journal:  Circ Res       Date:  1969-01       Impact factor: 17.367

Review 5.  Cor pulmonale.

Authors:  E Weitzenblum; A Chaouat
Journal:  Chron Respir Dis       Date:  2009       Impact factor: 2.444

Review 6.  Echocardiographic assessment of pulmonary hypertension: standard operating procedure.

Authors:  Luke S Howard; Julia Grapsa; David Dawson; Michael Bellamy; John B Chambers; Navroz D Masani; Petros Nihoyannopoulos; J Simon R Gibbs
Journal:  Eur Respir Rev       Date:  2012-09-01

7.  Stress Doppler echocardiography in relatives of patients with idiopathic and familial pulmonary arterial hypertension: results of a multicenter European analysis of pulmonary artery pressure response to exercise and hypoxia.

Authors:  Ekkehard Grünig; Sylvia Weissmann; Nicola Ehlken; Anna Fijalkowska; Christine Fischer; Thierry Fourme; Nazzareno Galié; Ardeschir Ghofrani; Rachel E Harrison; Sandrine Huez; Marc Humbert; Bart Janssen; Jaroslaw Kober; Rolf Koehler; Rajiv D Machado; Derliz Mereles; Robert Naeije; Horst Olschewski; Steeve Provencher; Frank Reichenberger; Kathleen Retailleau; Guido Rocchi; Gérald Simonneau; Adam Torbicki; Richard Trembath; Werner Seeger
Journal:  Circulation       Date:  2009-03-23       Impact factor: 29.690

8.  Chronic obstructive pulmonary disease and cardiac comorbidities: A cross-sectional study.

Authors:  Mohit Kaushal; Parth S Shah; Arti D Shah; Stani A Francis; Nihar V Patel; Kavit K Kothari
Journal:  Lung India       Date:  2016 Jul-Aug
  8 in total
  1 in total

1.  The Incidence and Prevalence of Pulmonary Hypertension in the COPD Population: A Systematic Review and Meta-Analysis.

Authors:  Limin Zhang; Yujia Liu; Shuai Zhao; Zhen Wang; Miaomiao Zhang; Su Zhang; Xinzhuo Wang; Shuang Zhang; Wenyan Zhang; Liying Hao; Guangyu Jiao
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-06-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.